PTEN mutations and evolving concepts in endometrial neoplasia

被引:48
作者
Latta, E [1 ]
Chapman, WB [1 ]
机构
[1] Univ Toronto, Dept Lab Med & Pathol, Toronto, ON, Canada
关键词
D O I
10.1097/00001703-200202000-00010
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Several recent advances have been made in our understanding of the pathogenesis of endometrial tumours, particularly endometrioid endometrial carcinoma (EEC). Mutations in the PTEN gene and microsatellite instability (MSI) are common genetic abnormalities in EECs, and distinguish these lesions from other histological subtypes of endometrial carcinoma. Endometrial precancers are monoclonal lesions that share a common genetic lineage with invasive EEC, including PTEN mutations and MSI Mutations of the PTEN tumour suppressor gene have been identified in histologically normal-appearing endometrium exposed to oestrogen, 18-55% of endometrial precancers and 26-80% of EECs. PTEN has been shown to play several roles in tumour suppression, including cell cycle arrest and promotion of apoptosis. Loss of PTEN function predisposes endometrial cells to neoplastic transformation, particularly in high-oestrogenic states. MSI is another common alteration seen in EECs and endometrial precancers, and some studies have reported an association between MSI and PTEN mutations. The replication error that results in MSI may facilitate the development of PTEN mutations in some, but not all, cases of EEC. The prognostic significance of PTEN gene mutations and MSI in endometrial carcinoma is controversial. Further study is needed to delineate the different pathogenetic pathways of EEC and their natural history.
引用
收藏
页码:59 / 65
页数:7
相关论文
共 83 条
[1]   ARCHITECTURAL AND NUCLEAR MORPHOMETRICAL FEATURES TOGETHER ARE MORE IMPORTANT PROGNOSTICATORS IN ENDOMETRIAL HYPERPLASIAS THAN NUCLEAR MORPHOMETRICAL FEATURES ALONE [J].
BAAK, JPA ;
NAUTA, JJP ;
WISSEBREKELMANS, ECM ;
BEZEMER, PD .
JOURNAL OF PATHOLOGY, 1988, 154 (04) :335-341
[2]   Prospective multicenter evaluation of the morphometric D-score for prediction of the outcome of endometrial hyperplasias [J].
Baak, JPA ;
Orbo, A ;
van Diest, PJ ;
Jiwa, M ;
de Bruin, P ;
Broeckaert, M ;
Snijders, W ;
Boodt, PJ ;
Fons, G ;
Burger, C ;
Verheijen, RHM ;
Houben, PWH ;
The, HS ;
Kenemans, P .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (07) :930-935
[3]   Atypical endometrial hyperplasia shares genomic abnormalities with endometrioid carcinoma by comparative genomic hybridization [J].
Baloglu, H ;
Cannizzaro, LA ;
Jones, J ;
Koss, LG .
HUMAN PATHOLOGY, 2001, 32 (06) :615-622
[4]  
Basil JB, 2000, CANCER-AM CANCER SOC, V89, P1758, DOI 10.1002/1097-0142(20001015)89:8<1758::AID-CNCR16>3.0.CO
[5]  
2-A
[6]   MLH1 and MSH2 protein expression as a pre-screening marker in hereditary and non-hereditary endometrial hyperplasia and cancer [J].
Berends, MJW ;
Hollema, H ;
Wu, Y ;
van der Sluis, T ;
Mensink, RGJ ;
ten Hoor, KA ;
Sijmons, RH ;
de Vries, EGE ;
Pras, E ;
Mourits, MJE ;
Hofstra, RMW ;
Buys, CHCM ;
Kleibeuker, JH ;
van der Zee, AGJ .
INTERNATIONAL JOURNAL OF CANCER, 2001, 92 (03) :398-403
[7]   A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens [J].
Bergeron, C ;
Nogales, FF ;
Masseroli, M ;
Abeler, V ;
Duvillard, P ;
Müller-Holzner, E ;
Pickartz, H ;
Wells, M .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1999, 23 (09) :1102-1108
[8]   PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis [J].
Besson, A ;
Robbins, SM ;
Yong, VW .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 263 (03) :605-611
[9]   2 PATHOGENETIC TYPES OF ENDOMETRIAL CARCINOMA [J].
BOKHMAN, JV .
GYNECOLOGIC ONCOLOGY, 1983, 15 (01) :10-17
[10]  
BURKS RT, 1994, ONCOGENE, V9, P1163